Multicancer early detection tests hold great promise for finding cancer early enough to save lives, but there are caveats that consumers should understand.

SV-based ctDNA Monitoring in Metastatic Breast Cancer (mBC) ...

Ultrasensitive, structural variant-based ctDNA monitoring reliably tracks therapeutic response and predicts progression in metastatic breast cancer, and is a strong independent prognostic marker in ...

For most patients diagnosed with kidney cancer, the standard playbook is clear. Immunotherapy and targeted therapies directed ...

India’s cancer crisis is driven by late detection, with most cases diagnosed late. Improving awareness, screening, and timely ...